3.00
3.45%
0.10
前日終値:
$2.90
開ける:
$2.95
24時間の取引高:
537.14K
Relative Volume:
1.47
時価総額:
$147.26M
収益:
$226.63M
当期純損益:
$15.38M
株価収益率:
-60.00
EPS:
-0.05
ネットキャッシュフロー:
$35.61M
1週間 パフォーマンス:
+23.97%
1か月 パフォーマンス:
+5.63%
6か月 パフォーマンス:
-29.08%
1年 パフォーマンス:
-27.54%
Puma Biotechnology Inc Stock (PBYI) Company Profile
名前
Puma Biotechnology Inc
セクター
電話
(424) 248-6500
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
PBYI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
PBYI | 3.00 | 147.26M | 226.63M | 15.38M | 35.61M | -0.05 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-09-28 | アップグレード | Citigroup | Neutral → Buy |
2020-06-25 | 再開されました | BofA/Merrill | Underperform |
2019-10-08 | ダウングレード | Goldman | Neutral → Sell |
2019-05-10 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2019-05-10 | ダウングレード | Citigroup | Buy → Neutral |
2019-01-17 | 開始されました | Leerink Partners | Mkt Perform |
2019-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
2018-11-19 | アップグレード | Goldman | Sell → Neutral |
2018-11-02 | ダウングレード | BofA/Merrill | Buy → Underperform |
2018-11-02 | ダウングレード | JP Morgan | Neutral → Underweight |
2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
2018-09-17 | 開始されました | Goldman | Sell |
2018-05-11 | 繰り返されました | Stifel | Buy |
2017-11-10 | 繰り返されました | Citigroup | Buy |
2017-11-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-10-02 | 繰り返されました | Stifel | Buy |
2017-09-11 | 繰り返されました | Credit Suisse | Outperform |
2017-07-10 | 再開されました | Leerink Partners | Outperform |
2017-06-06 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-05-25 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-03-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Puma Biotechnology Inc (PBYI) 最新ニュース
Puma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to Buy - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
Puma commences Phase II trial of alisertib for breast cancer treatment - Clinical Trials Arena
Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment | PBYI Stock News - StockTitan
245,695 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by Los Angeles Capital Management LLC - MarketBeat
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance
Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com
Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq
Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks
Puma Biotechnology Q3 2024 Earnings Preview - MSN
Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise
Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - sharewise
Puma Biotechnology Grants 5,625-Share Inducement Award to New Employee | PBYI | PBYI Stock News - StockTitan
Puma Biotechnology (NASDAQ:PBYI) Raised to "Strong-Buy" at StockNews.com - MarketBeat
Puma Biotechnology (PBYI) Set to Announce Quarterly Earnings on Thursday - MarketBeat
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ - The Bakersfield Californian
3 US Penny Stocks With Market Caps Under $700M - Simply Wall St
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - BioSpace
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results | PBYI Stock News - StockTitan
Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
What is Zacks Research's Forecast for PBYI FY2026 Earnings? - MarketBeat
Equities Analysts Offer Predictions for PBYI Q3 Earnings - MarketBeat
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? - Yahoo Finance
Puma Biotechnology quickly drops after patents for Tagrisso ruled invalid - MSN
FY2025 EPS Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) Decreased by Zacks Research - MarketBeat
Frazier Life Sciences Management L.P. Purchases 246,264 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Affinity Asset Advisors LLC Makes New $815,000 Investment in Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Fred Alger Management LLC Raises Stake in Hamilton Lane Incorporated (NASDAQ:HLNE) - MarketBeat
Hsbc Holdings PLC Has $4.29 Million Position in Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - MarketBeat
The growth track for Humacyte Inc (HUMA) has changed recently - SETE News
Humacyte: Navigating The FDA Uncertainty And ATEV’s Potential (NASDAQ:HUMA) - Seeking Alpha
Puma VCT 13 Launches £70M Share Offer - TipRanks
HUTCHMED (NASDAQ:HCM) Shares Gap Down to $17.38 - MarketBeat
It is Poised to be a Bull Market for Puma Biotechnology Inc (PBYI) - SETE News
American Century Companies Inc. Sells 186,924 Shares of Foot Locker, Inc. (NYSE:FL) - Defense World
Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat
Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter
Insider Selling: Sebelius Kathleen, Humacyte Inc [HUMA] Director divested 5,182 shares - Knox Daily
A$AP Rocky’s Lineup of Puma Sneakers Is Quickly Growing Bigger - Yahoo! Voices
Achilles gains on plans to explore strategic options - XM
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know - Benzinga
Puma VCT 13 PLC Executes Share Buyback - TipRanks
Puma Biotechnology Inc (PBYI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):